Ph II Study of Cabozantinib With Pembrolizumab in Metastatic Gastric and Gastroesophageal Adenocarcinoma

Conditions:   Gastric Adenocarcinoma;   GastroEsophageal Cancer Interventions:   Drug: Cabozantinib;   Drug: Pembrolizumab Sponsors:   University of California, Irvine;   Exelixis Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials